Laddar...
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Androgen receptor (AR) mutations arise in patients developing resistance to hormone deprivation therapies. Here we describe BAY 1024767, a thiohydantoin derivative with strong antagonistic activity against nine AR variants with mutations located in the AR ligand-binding domain (LBD), and against wil...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4868737/ https://ncbi.nlm.nih.gov/pubmed/26760770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6864 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|